Neuronetics, Inc.
STIM
$3.20
-$0.20-5.88%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 131.66% | 83.59% | 10.73% | 3.61% | -6.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 131.66% | 83.59% | 10.73% | 3.61% | -6.59% |
| Cost of Revenue | 376.47% | 275.08% | 164.85% | -26.00% | -11.68% |
| Gross Profit | 45.81% | 20.25% | -12.33% | 19.02% | -4.66% |
| SG&A Expenses | 30.17% | 42.83% | 14.46% | 4.51% | 3.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 84.98% | 77.08% | 46.08% | -1.86% | -0.01% |
| Operating Income | 5.28% | -60.58% | -330.23% | 12.88% | -15.76% |
| Income Before Tax | -0.07% | -61.17% | -135.84% | -42.06% | -100.61% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.07% | -61.17% | -135.84% | -42.06% | -100.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.93% | -60.99% | -135.48% | -42.06% | -100.61% |
| EBIT | 5.28% | -60.58% | -330.23% | 12.88% | -15.76% |
| EBITDA | 9.87% | -60.39% | -397.45% | 13.99% | -16.68% |
| EPS Basic | 53.27% | 22.80% | -86.55% | -35.55% | -90.90% |
| Normalized Basic EPS | 52.47% | 22.87% | -231.55% | 9.44% | -19.94% |
| EPS Diluted | 53.27% | 22.80% | -86.55% | -35.55% | -90.90% |
| Normalized Diluted EPS | 52.47% | 22.87% | -231.55% | 9.44% | -19.94% |
| Average Basic Shares Outstanding | 120.22% | 108.55% | 26.25% | 4.82% | 5.11% |
| Average Diluted Shares Outstanding | 120.22% | 108.55% | 26.25% | 4.82% | 5.11% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |